N/A N=677 Unexpected Cardiac Arrest in Intensive Care Unit
Heart Arrest
Primary: Number of Patients With Unexpected Cardiac Arrest — 677; 30,722 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=329 Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial
Cardiac Arrest
Primary: Survival With Good Neurobehavioral Outcome — 48; 48; 85; 76 Participants — p=0.63
Phase 3 N=295 Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial
Cardiac Arrest
Primary: Survival With Good Neurobehavioral Outcome — 27; 15; 111; 107 Participants — p=0.14
Phase 1 N=192 Automatic External Defibrillation Monitoring in Cardiac Arrest
Death, Sudden, Cardiac · Ventricular Fibrillation · Tachycardia, Ventricular
Primary: Number of Participants Without Defibrillation — 94; 97 participants
N/A N=15 ECPR for Refractory Out-Of-Hospital Cardiac Arrest
Cardiac Arrest · Heart Arrest · Sudden Cardiac Arrest
Primary: Emergency Department Arrivals Under 30 Minutes — 5 Participants
Phase 2 N=397 Calcium for Out-of-Hospital Cardiac Arrest
Heart Arrest, Out-Of-Hospital
Primary: Number of Participants With Sustained Return of Spontaneous Circulation — 37; 53 Participants
N/A N=542 A Pilot Study of Intra-arrest Therapeutic Hypothermia in Patients Suffering Non-Traumatic Out of Hospital Cardiac Arrest
Out-of-Hospital Cardiac Arrest
Primary: Number of Participants Who Survived Up To Hospital Discharge — 24; 40 Participants
Phase 2 N=48 Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest
Cardiac Arrest
Primary: Coenzyme Q10 Plasma Levels — 185; 207; 113; 441 ng/mL
N/A N=1,076 Improving Cardiac Arrest Diagnostic Accuracy of Emergency Medical Dispatchers
Cardiac Arrest
Primary: Number of Participants With Agonal Breathing — 176; 87 Participants
Phase 3 N=501 Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest
Heart Arrest
Primary: Number of Participants With Return of Spontaneous Circulation — 100; 86 participants
Phase 3 N=3,024 Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Cardiac Arrest
Primary: Number of Participants Who Survive From the Time of Cardiac Arrest to Hospital Discharge — 237; 233; 222 participants
N/A N=3,889 Improve Sudden Cardiac Arrest Study
Sudden Cardiac Arrest · Ventricular Arrythmia
Primary: Time to the First Occurrence of a Ventricular Arrhythmia — 32.5; 18.3 Estimated 24-Month VT-VF Pct of Patients
N/A N=14 Open Pilot Trial of a Mind-body Program for Cardiac Arrest Survivors and Their Caregivers
Emotional Distress · Cardiac Arrest
Primary: Recruitment Feasibility Assessed by the Number of Eligible Dyads Enrolled — 7 dyads
Phase 2 N=100 Physiologic Effects of Steroids in Cardiac Arrest
Inhospital Cardiac Arrest
Primary: Early Postresuscitation Arterial Blood Pressure (mmHg) Measured Through Institution of Invasive Intra-arterial Pressure Monitoring (as Feasible). — 78.4; 75.1 mmHg…
Phase 2 N=10 Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
Cardiac Arrest · Sudden Cardiac Arrest
Primary: Prevalence of Low Serum CoQ10 Levels in Cardiac Arrest Patients — 0.706; 0.66 ug/mL
Phase 2 N=14 Amantadine to Speed Awakening After Cardiac Arrest
Coma · Heart Arrest · Anoxia
Primary: Rate of Awakening (Number of Patients Who Are Able to Follow Commands) — 2; 2 Participants
N/A N=4,231 Circulation Improving Resuscitation Care (CIRC)
Cardiac Arrest · Cardiopulmonary Resuscitation
Primary: Hospital Discharge — 196; 233 participants
N/A N=48 Hemodynamic Effects of Standard Cardiopulmonary Resuscitation (CPR), Active Compression Decompression CPR With an Inspiratory Impedance Device, and Standard CPR With an Intrathoracic Pressure Regulator During Out-of-hospital Cardiac Arrest
Cardiac Arrest · Sudden Cardiac Death
Primary: Mean Systolic and Diastolic Blood Pressures — 80.38; 121.21; 61.37; 15.52 mmHg
Phase 2 N=2 Washington Study of Hemofiltration After Out-of-Hospital Cardiac Arrest
Cardiac Arrest
Primary: Intervention Compliance — 1 participants
Phase 3 N=727 Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest
Cardiac Arrest
Primary: Survival to Hospital Discharge. — 8; 11 Participants
Phase 2 N=50 Bicarbonate in Patients With Out-of-hospital Cardiac Arrest
Cardiac Arrest · Metabolic Acidosis
Primary: Return of Spontaneous Circulation (ROSC) — 4; 16 ROSC percents of each group
N/A N=90 Donor After Circulatory Death Heart CAP Trial
Heart Transplant
Primary: Patient Survival — 75 Participants
Phase 3 N=1,359 Induction of Mild Hypothermia Following Out-of-hospital Cardiac Arrest
Out-of-hospital Cardiac Arrest
Primary: Number Alive at Hospital Discharge — 187; 183; 62; 76 participants
N/A N=5 Pre-hospital ECMO in Advanced Resuscitation in Patients With Refractory Cardiac Arrest. ( SUB30 )
Death, Sudden, Cardiac · Out-Of-Hospital Cardiac Arrest · Ventricular Fibrillation
Primary: Proportion of Patients Successfully Established With Pre-hospital ECPR — 0 Participants
N/A N=27 Tourniquets Increase Proximal Pressure
Blood Pressure
Primary: Systolic Blood Pressure During Application of the CAT Tourniquets — 129; 76 mmHg
Phase 2 N=50 Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
Cardiac Arrest
Primary: Time to Shock Reversal — 55; 49 hours
N/A N=2,260 Effectiveness of Dispatch-Assisted Cardiopulmonary Resuscitation (CPR) Instructions
Cardiac Arrest
Primary: Sensitivity — 1012 Participants
Phase 4 N=37 Antiplatelet Therapy After Cardiac Arrest
Cardiac Arrest · Postresuscitation Syndrome · Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)
Primary: VerifyNow P2Y12Test - Platelet Reactivity — 238; 101 PRU
Phase 4 N=23,687 Continuous Chest Compressions vs AHA Standard CPR of 30:2
Out of Hospital Cardiac Arrest
Primary: Number of Participants Who Survive From the Time of Cardiac Arrest to Hospital Discharge — 1072; 1127 participants
N/A N=47 Synchronized Cardiac Assist for Cardiogenic Shock
Shock, Cardiogenic · High Risk Percutaneous Coronary Interventions
Primary: Number of Participants With Device and Procedure Related Serious Adverse Events — 11; 5 Participants